KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biogen (BIIB) Equity Income (2019 - 2022)

Historic Equity Income for Biogen (BIIB) over the last 8 years, with Q2 2022 value amounting to $5.9 million.

  • Biogen's Equity Income fell 8279.88% to $5.9 million in Q2 2022 from the same period last year, while for Mar 2023 it was $5.9 million, marking a year-over-year decrease of 8815.26%. This contributed to the annual value of $2.6 million for FY2022, which is 9255.01% down from last year.
  • Latest data reveals that Biogen reported Equity Income of $5.9 million as of Q2 2022, which was down 8279.88% from -$3.3 million recorded in Q1 2022.
  • Biogen's Equity Income's 5-year high stood at $34.3 million during Q2 2021, with a 5-year trough of -$140.9 million in Q4 2019.
  • Over the past 4 years, Biogen's median Equity Income value was -$8.2 million (recorded in 2020), while the average stood at -$11.9 million.
  • Per our database at Business Quant, Biogen's Equity Income soared by 19263.8% in 2020 and then tumbled by 8279.88% in 2022.
  • Quarter analysis of 4 years shows Biogen's Equity Income stood at -$140.9 million in 2019, then soared by 112.78% to $18.0 million in 2020, then fell by 1.67% to $17.7 million in 2021, then crashed by 66.67% to $5.9 million in 2022.
  • Its last three reported values are $5.9 million in Q2 2022, -$3.3 million for Q1 2022, and $17.7 million during Q4 2021.